Cargando…
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a rare malignancy of mesothelial cells with increasing incidence, and in many cases, dismal prognosis due to its aggressiveness and lack of effective therapies. Environmental and occupational exposure to asbestos is considered the main aetiological factor for...
Autores principales: | Urso, Loredana, Cavallari, Ilaria, Sharova, Evgeniya, Ciccarese, Francesco, Pasello, Giulia, Ciminale, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964675/ https://www.ncbi.nlm.nih.gov/pubmed/31819191 http://dx.doi.org/10.1038/s41416-019-0661-9 |
Ejemplares similares
-
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019) -
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists
por: Urso, Loredana, et al.
Publicado: (2017) -
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
por: Cavallari, Ilaria, et al.
Publicado: (2021) -
Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells
por: Ciccarese, Francesco, et al.
Publicado: (2020) -
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
por: Cavallari, Ilaria, et al.
Publicado: (2023)